Form 4: Vor Biopharma Insider Sells Over 1.2 Million Shares

Reprogrammed Interchange LLC, a 10% owner and director of Vor Biopharma Inc., sold 1,263,647 shares of common stock in early September 2025.

Summary

• Reprogrammed Interchange LLC, identified as both a Director and a 10% Owner of Vor Biopharma Inc. (VOR), reported multiple sales of common stock.
• A total of 1,263,647 shares of common stock were sold across three separate transactions between September 8, 2025, and September 10, 2025.
• The sales occurred at weighted average prices ranging from $1.8151 to $2.0004 per share.
• The total value of the shares sold amounts to approximately $2,456,955.
• Following these transactions, Reprogrammed Interchange LLC beneficially owns 34,213,292 shares of Vor Biopharma Inc. common stock.
• Reid Hoffman, who shares control over Reprogrammed Interchange LLC, may be deemed a beneficial owner but disclaims ownership except to the extent of his pecuniary interest.

Sentiment

Score: 3

Explanation: The sentiment is negative due to substantial insider selling by a key stakeholder, which often signals a lack of confidence or a strategic divestment, potentially impacting investor perception.

Negatives

• A significant volume of insider selling by a 10% owner and director, totaling over 1.2 million shares, could be perceived negatively by the market.
• The sales occurred over three consecutive trading days, indicating a sustained reduction in the insider's stake.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Management Comments

• Reid Hoffman disclaims beneficial ownership of the securities held by Reprogrammed Interchange LLC, except to the extent of his pecuniary interest therein.

Industry Context

This Form 4 filing reports an insider transaction and does not provide information on broader industry trends or competitive landscape.

Related Party Transactions

• Reprogrammed Interchange LLC, a 10% owner and director of Vor Biopharma Inc., engaged in open market sales of common stock.

Stakeholder Impact

• Shareholders may interpret the significant insider selling as a negative signal, potentially leading to decreased investor confidence and downward pressure on the stock price.
• The reduction in stake by a major owner could raise questions among investors about the company's near-term prospects.

Key Dates

Recommendation

The substantial insider selling by a 10% owner and director, Reprogrammed Interchange LLC, signals a significant reduction in their stake. Such a move by a well-informed party often indicates a lack of confidence in the company's near-term prospects or a strategic decision to divest, which typically exerts downward pressure on the stock price. For a seasoned investor, this would warrant a 'sell' recommendation, or at least a re-evaluation of their position, given the negative signal from a key insider.

Keywords

Vor Biopharma, VOR, Insider Selling, Form 4, Stock Sale, Reprogrammed Interchange LLC, Reid Hoffman, Beneficial Ownership